Longboard Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol: LBPH on Nasdaq
Industry: Pharmaceutical Preparations
Location: 4275 Executive Square, Suite 950, La Jolla, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	1	-50.1K	100%	$41.76	-$2.09M
Net	-1	-50.1K	-100%		-$2.09M

Showing 1 to 3 of 3 entries

Longboard Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Brandi Roberts	Executive VP and CFO	$63.4K			Dec 2, 2024
Randall Kaye	Executive Vice President & CMO	$0	-$2.09M	-100%	Dec 2, 2024
Kevin Robert Lind	President and CEO, Director	$0			Dec 2, 2024
Paul J. Sekhri	Director				Dec 2, 2024
Casey Lynch	Director				Dec 2, 2024
Jane Tiller	Director				May 25, 2023
Philip Perera	Cmo				Feb 9, 2022
Arena Pharmaceuticals Inc	Former 10% Owner				Jan 25, 2024
Corinne Le Goff	Director				Dec 2, 2024
Vincent Aurentz	Director				Dec 2, 2024
Phillip M. Schneider	Director				Dec 2, 2024

Recent Insider Transactions by Companies or Individuals for Longboard Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.